Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K James

Showing results (1001-1010 of 1,119) with videos related to

Pageof 112
Sort By:
Circulation|October 31, 2013
Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trialLars Wallentin, Daniel Lindholm, Agneta Siegbahn, et al.
Genes|January 12, 2021
Comparative Genomics Provides Insights into the Taxonomy of <i>Azoarcus</i> and Reveals Separate Origins of <i>Nif</i> Genes in the Proposed <i>Azoarcus</i> and <i>Aromatoleum</i> GeneraRoberto Tadeu Raittz, Camilla Reginatto De Pierri, Marta Maluk, et al.
American Heart Journal|June 4, 2018
Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysisBenjamin M Scirica, Sameer Bansilal, Farideh Davoudi, et al.
International Journal of Cancer|April 15, 2011
Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infectionRichard M Haupt, Cosette M Wheeler, Darron R Brown, et al.
Journal of Medicinal Chemistry|July 19, 1996
3-[2-(N-phenylacetamide)]-1,5-benzodiazepines: orally active, binding selective CCK-A agonistsT M Willson, B R Henke, T M Momtahen, et al.
American Heart Journal|June 23, 2014
Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trialAnna Kotsia, Emmanouil S Brilakis, Claes Held, et al.
The American Journal of Cardiology|July 14, 2022
Outcomes After Acute Coronary Syndrome in Patients With Diabetes Mellitus and Peripheral Artery Disease (from the TRACER, TRILOGY-ACS, APPRAISE-2, and PLATO Clinical Trials)Rubina Attar, Angie Wu, Daniel Wojdyla, et al.
Microorganisms|August 28, 2025
Assessing SARS-CoV-2 Rare Mutations and Transmission in New York City by NGSDakai Liu, Harlan Pietz, George D Rodriguez, et al.
Journal of Bacteriology|November 20, 2012
Partial complementation of Sinorhizobium meliloti bacA mutant phenotypes by the Mycobacterium tuberculosis BacA proteinM F F Arnold, A F Haag, S Capewell, et al.
American Heart Journal|March 21, 2016
Pooled analysis of adverse event collection from 4 acute coronary syndrome trialsAndré Zimerman, Renato D Lopes, Amanda L Stebbins, et al.
Pageof 112

Showing results (1001-1010 of 1,119) with videos related to

Sort By:
Pageof 112
Circulation|October 31, 2013
Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trialLars Wallentin, Daniel Lindholm, Agneta Siegbahn, et al.
Genes|January 12, 2021
Comparative Genomics Provides Insights into the Taxonomy of <i>Azoarcus</i> and Reveals Separate Origins of <i>Nif</i> Genes in the Proposed <i>Azoarcus</i> and <i>Aromatoleum</i> GeneraRoberto Tadeu Raittz, Camilla Reginatto De Pierri, Marta Maluk, et al.
American Heart Journal|June 4, 2018
Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysisBenjamin M Scirica, Sameer Bansilal, Farideh Davoudi, et al.
International Journal of Cancer|April 15, 2011
Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infectionRichard M Haupt, Cosette M Wheeler, Darron R Brown, et al.
Journal of Medicinal Chemistry|July 19, 1996
3-[2-(N-phenylacetamide)]-1,5-benzodiazepines: orally active, binding selective CCK-A agonistsT M Willson, B R Henke, T M Momtahen, et al.
American Heart Journal|June 23, 2014
Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trialAnna Kotsia, Emmanouil S Brilakis, Claes Held, et al.
The American Journal of Cardiology|July 14, 2022
Outcomes After Acute Coronary Syndrome in Patients With Diabetes Mellitus and Peripheral Artery Disease (from the TRACER, TRILOGY-ACS, APPRAISE-2, and PLATO Clinical Trials)Rubina Attar, Angie Wu, Daniel Wojdyla, et al.
Microorganisms|August 28, 2025
Assessing SARS-CoV-2 Rare Mutations and Transmission in New York City by NGSDakai Liu, Harlan Pietz, George D Rodriguez, et al.
Journal of Bacteriology|November 20, 2012
Partial complementation of Sinorhizobium meliloti bacA mutant phenotypes by the Mycobacterium tuberculosis BacA proteinM F F Arnold, A F Haag, S Capewell, et al.
American Heart Journal|March 21, 2016
Pooled analysis of adverse event collection from 4 acute coronary syndrome trialsAndré Zimerman, Renato D Lopes, Amanda L Stebbins, et al.
Pageof 112